Antimicrobial Agents and Chemotherapy, January 1998, p. 100-107, Vol. 42, No. 1
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
andThe Rockefeller University, New York, New York 10021
Received 30 June 1997/Returned for modification 11 September 1997/Accepted 4 November 1997
Of 41 methicillin-resistant coagulase-negative staphylococcal
clinical isolates collected during a 5-month period between late 1995 and early 1996, 28 showed tube dilution teicoplanin MICs of 4 to 8 µg/ml which increased to 16 to 32 µg/ml upon prolonged incubation.
Cultures of such bacteria were heterogeneous; they contained
subpopulations with frequencies of 10
5 to
10
4 that could grow on up to 50 µg of teicoplanin per
ml. The same cultures were also heterogeneous with respect to
susceptibility to vancomycin; while the MICs for the majority of cells
were 2 to 4 µg/ml, subpopulations that could grow on 6 to 12 µg of
vancomycin per ml were also present at frequencies of 10
5
to 10
7. Selective enrichment of such cultures for the
resistant subpopulation occurred with relative ease under laboratory
conditions. Heterogeneous phenotypes for teicoplanin (but not for
vancomycin) susceptibility were also identified in several
Staphylococcus epidermidis isolates collected during the
preantibiotic era. The addition of half the MIC of teicoplanin
inhibited autolysis and caused formation of cellular aggregates which
disintegrated to individual bacteria in the stationary phase when the
titer of teicoplanin in the medium fell to undetectable levels,
indicating removal of the antibiotic from the culture medium
by the bacteria.
Present address: Istituto di Igiene e Medicina Preventiva,
Università "Federico I" di Napoli, 80131 Naples, Italy.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |